United Therapeutics Corporation OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax
United Therapeutics Corporation (UTHR) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax of -$11.00 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-02.
Discontinued › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax · last filed 2023-08-02
- United Therapeutics Corporation oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, after tax for the quarter ending 2023-06-30 was -$11.00M.
- United Therapeutics Corporation oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, after tax for the quarter ending 2023-03-31 was $19.90M.
- United Therapeutics Corporation oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, after tax for the quarter ending 2022-12-31 was $10.00M.
- United Therapeutics Corporation oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, after tax for the quarter ending 2022-09-30 was -$18.80M.
- United Therapeutics Corporation oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, after tax for fiscal 2022 was -$51.80M.
- United Therapeutics Corporation oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, after tax for fiscal 2021 was -$15.00M, a 323.88% decline from fiscal 2020.
- United Therapeutics Corporation oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, after tax for fiscal 2020 was $6.70M, a 11.67% increase from fiscal 2019.
- United Therapeutics Corporation oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, after tax for fiscal 2019 was $6.00M.
| Period end | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax 3 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax 6 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax 9 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax 12 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2023-06-30 | -$11.00M 10-Q · filed 2023-08-02 | $8.90M 10-Q · filed 2023-08-02 | $18.90M derived: sum of 3 quarters · filed 2023-08-02 | $100.00K derived: sum of 4 quarters · filed 2023-08-02 | |
| 2023-03-31 | $19.90M 10-Q · filed 2023-05-03 | $29.90M derived: sum of 2 quarters · filed 2023-05-03 | $11.10M derived: sum of 3 quarters · filed 2023-05-03 | -$300.00K derived: sum of 4 quarters · filed 2023-08-02 | |
| 2022-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$8.80M derived: sum of 2 quarters · filed 2023-02-22 | -$20.20M derived: sum of 3 quarters · filed 2023-08-02 | -$51.80M 10-K · filed 2023-02-22 | |
| 2022-09-30 | -$18.80M 10-Q · filed 2022-11-02 | -$30.20M derived: sum of 2 quarters · filed 2023-08-02 | -$61.80M 10-Q · filed 2022-11-02 | -$70.30M derived: sum of 4 quarters · filed 2023-08-02 | |
| 2022-06-30 | -$11.40M 10-Q · filed 2023-08-02 | -$43.00M 10-Q · filed 2023-08-02 | -$51.50M derived: sum of 3 quarters · filed 2023-08-02 | -$53.10M derived: sum of 4 quarters · filed 2023-08-02 | |
| 2022-03-31 | -$31.60M 10-Q · filed 2023-05-03 | -$40.10M derived: sum of 2 quarters · filed 2023-05-03 | -$41.70M derived: sum of 3 quarters · filed 2023-05-03 | -$43.70M derived: sum of 4 quarters · filed 2023-05-03 | |
| 2021-12-31 | -$8.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$10.10M derived: sum of 2 quarters · filed 2023-02-22 | -$12.10M derived: sum of 3 quarters · filed 2023-02-22 | -$15.00M 10-K · filed 2023-02-22 | |
| 2021-09-30 | -$1.60M 10-Q · filed 2022-11-02 | -$3.60M derived: sum of 2 quarters · filed 2022-11-02 | -$6.50M 10-Q · filed 2022-11-02 | -$8.40M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-06-30 | -$2.00M 10-Q · filed 2022-08-03 | -$4.90M 10-Q · filed 2022-08-03 | -$6.80M derived: sum of 3 quarters · filed 2023-02-22 | -$9.50M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-03-31 | -$2.90M 10-Q · filed 2022-05-04 | -$4.80M derived: sum of 2 quarters · filed 2023-02-22 | -$7.50M derived: sum of 3 quarters · filed 2023-02-22 | -$6.40M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2020-12-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$4.60M derived: sum of 2 quarters · filed 2023-02-22 | -$3.50M derived: sum of 3 quarters · filed 2023-02-22 | $6.70M 10-K · filed 2023-02-22 | |
| 2020-09-30 | -$2.70M 10-Q · filed 2021-11-03 | -$1.60M derived: sum of 2 quarters · filed 2021-11-03 | $8.60M 10-Q · filed 2021-11-03 | $8.60M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $1.10M 10-Q · filed 2021-08-04 | $11.30M 10-Q · filed 2021-08-04 | $11.30M derived: sum of 3 quarters · filed 2022-02-24 | $12.30M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $10.20M 10-Q · filed 2021-05-05 | $10.20M derived: sum of 2 quarters · filed 2022-02-24 | $11.20M derived: sum of 3 quarters · filed 2022-02-24 | $13.60M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.00M derived: sum of 2 quarters · filed 2022-02-24 | $3.40M derived: sum of 3 quarters · filed 2022-02-24 | $6.00M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $1.00M 10-Q · filed 2020-10-28 | $3.40M derived: sum of 2 quarters · filed 2020-10-28 | $6.00M 10-Q · filed 2020-10-28 | $9.20M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | $2.40M 10-Q · filed 2020-07-29 | $5.00M 10-Q · filed 2020-07-29 | $8.20M derived: sum of 3 quarters · filed 2021-02-24 | $7.50M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | $2.60M 10-Q · filed 2020-04-29 | $5.80M derived: sum of 2 quarters · filed 2021-02-24 | $5.10M derived: sum of 3 quarters · filed 2021-02-24 | $4.60M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2018-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $2.50M derived: sum of 2 quarters · filed 2021-02-24 | $2.00M derived: sum of 3 quarters · filed 2021-02-24 | -$400.00K 10-K · filed 2021-02-24 | |
| 2018-09-30 | -$700.00K 10-Q · filed 2019-10-30 | -$1.20M derived: sum of 2 quarters · filed 2019-10-30 | -$3.60M 10-Q · filed 2019-10-30 | -$5.00M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-06-30 | -$500.00K 10-Q · filed 2019-07-31 | -$2.90M 10-Q · filed 2019-07-31 | -$4.30M derived: sum of 3 quarters · filed 2020-02-26 | -$4.60M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-03-31 | -$2.40M 10-Q · filed 2019-05-01 | -$3.80M derived: sum of 2 quarters · filed 2020-02-26 | -$4.10M derived: sum of 3 quarters · filed 2020-02-26 | -$4.40M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2017-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$1.70M derived: sum of 2 quarters · filed 2020-02-26 | -$2.00M derived: sum of 3 quarters · filed 2020-02-26 | -$1.90M 10-K · filed 2020-02-26 | |
| 2017-09-30 | -$300.00K 10-Q · filed 2018-10-31 | -$600.00K derived: sum of 2 quarters · filed 2018-10-31 | -$500.00K 10-Q · filed 2018-10-31 | ||
| 2017-06-30 | -$300.00K 10-Q · filed 2018-08-01 | -$200.00K 10-Q · filed 2018-08-01 | |||
| 2017-03-31 | $100.00K 10-Q · filed 2018-05-02 | ||||
| 2015-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | -$60.00K derived: sum of 2 quarters · filed 2016-02-25 | -$59.00K derived: sum of 3 quarters · filed 2016-02-25 | -$74.00K 10-K · filed 2016-02-25 | |
| 2015-09-30 | -$41.00K 10-Q · filed 2015-10-27 | -$40.00K derived: sum of 2 quarters · filed 2015-10-27 | -$55.00K 10-Q · filed 2015-10-27 | -$280.00K derived: sum of 4 quarters · filed 2017-02-22 | |
| 2015-06-30 | $1.00K 10-Q · filed 2015-07-28 | -$14.00K 10-Q · filed 2015-07-28 | -$239.00K derived: sum of 3 quarters · filed 2017-02-22 | -$230.00K derived: sum of 4 quarters · filed 2017-02-22 | |
| 2015-03-31 | -$15.00K 10-Q · filed 2015-04-28 | -$240.00K derived: sum of 2 quarters · filed 2017-02-22 | -$231.00K derived: sum of 3 quarters · filed 2017-02-22 | -$301.00K derived: sum of 4 quarters · filed 2017-02-22 | |
| 2014-12-31 | -$225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | -$216.00K derived: sum of 2 quarters · filed 2017-02-22 | -$286.00K derived: sum of 3 quarters · filed 2017-02-22 | -$300.00K 10-K · filed 2017-02-22 | -$250.00K 10-K · filed 2015-02-24 |
| 2014-09-30 | $9.00K 10-Q · filed 2015-10-27 | -$61.00K derived: sum of 2 quarters · filed 2015-10-27 | -$75.00K 10-Q · filed 2015-10-27 | -$132.00K derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-06-30 | -$70.00K 10-Q · filed 2015-07-28 | -$84.00K 10-Q · filed 2015-07-28 | -$141.00K derived: sum of 3 quarters · filed 2016-02-25 | -$153.00K derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-03-31 | -$13.00K 10-Q · filed 2015-04-28 | -$71.00K derived: sum of 2 quarters · filed 2016-02-25 | -$83.00K derived: sum of 3 quarters · filed 2016-02-25 | -$118.00K derived: sum of 4 quarters · filed 2016-02-25 | |
| 2013-12-31 | -$58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | -$70.00K derived: sum of 2 quarters · filed 2016-02-25 | -$105.00K derived: sum of 3 quarters · filed 2016-02-25 | -$128.00K 10-K · filed 2016-02-25 | |
| 2013-09-30 | -$12.00K 10-Q · filed 2014-10-28 | -$47.00K derived: sum of 2 quarters · filed 2014-10-28 | -$70.00K 10-Q · filed 2014-10-28 | -$112.00K derived: sum of 4 quarters · filed 2015-02-24 | |
| 2013-06-30 | -$35.00K 10-Q · filed 2014-07-29 | -$58.00K 10-Q · filed 2014-07-29 | -$100.00K derived: sum of 3 quarters · filed 2015-02-24 | -$28.00K derived: sum of 4 quarters · filed 2015-02-24 | |
| 2013-03-31 | -$23.00K 10-Q · filed 2014-04-29 | -$65.00K derived: sum of 2 quarters · filed 2015-02-24 | $7.00K derived: sum of 3 quarters · filed 2015-02-24 | -$8.00K derived: sum of 4 quarters · filed 2015-02-24 | |
| 2012-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $30.00K derived: sum of 2 quarters · filed 2015-02-24 | $15.00K derived: sum of 3 quarters · filed 2015-02-24 | $67.00K 10-K · filed 2015-02-24 | |
| 2012-09-30 | $72.00K 10-Q · filed 2013-10-29 | $57.00K derived: sum of 2 quarters · filed 2013-10-29 | $109.00K 10-Q · filed 2013-10-29 | $177.00K derived: sum of 4 quarters · filed 2014-02-25 | |
| 2012-06-30 | -$15.00K 10-Q · filed 2013-07-25 | $36.00K 10-Q · filed 2013-07-25 | $105.00K derived: sum of 3 quarters · filed 2014-02-25 | -$14.00K derived: sum of 4 quarters · filed 2014-02-25 | |
| 2012-03-31 | $52.00K 10-Q · filed 2013-04-25 | $120.00K derived: sum of 2 quarters · filed 2014-02-25 | $1.00K derived: sum of 3 quarters · filed 2014-02-25 | -$125.00K derived: sum of 4 quarters · filed 2014-02-25 | |
| 2011-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$51.00K derived: sum of 2 quarters · filed 2014-02-25 | -$177.00K derived: sum of 3 quarters · filed 2014-02-25 | $6.00K 10-K · filed 2014-02-25 | |
| 2011-09-30 | -$119.00K 10-Q · filed 2012-11-01 | -$245.00K derived: sum of 2 quarters · filed 2012-11-01 | -$62.00K 10-Q · filed 2012-11-01 | $9.00K derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-06-30 | -$126.00K 10-Q · filed 2012-07-26 | $57.00K 10-Q · filed 2012-07-26 | $128.00K derived: sum of 3 quarters · filed 2013-02-26 | $145.00K derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-03-31 | $183.00K 10-Q · filed 2012-04-26 | $254.00K derived: sum of 2 quarters · filed 2013-02-26 | $271.00K derived: sum of 3 quarters · filed 2013-02-26 | $270.00K derived: sum of 4 quarters · filed 2013-02-26 | |
| 2010-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $88.00K derived: sum of 2 quarters · filed 2013-02-26 | $87.00K derived: sum of 3 quarters · filed 2013-02-26 | $134.00K 10-K · filed 2013-02-26 | |
| 2010-09-30 | $17.00K 10-Q · filed 2011-10-27 | $16.00K derived: sum of 2 quarters · filed 2011-10-27 | $63.00K 10-Q · filed 2011-10-27 | ||
| 2010-06-30 | -$1.00K 10-Q · filed 2011-07-28 | $46.00K 10-Q · filed 2011-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |